Evidence map›Paper›PMID 35918366›Full record

ArticleScientific reports2022

Reciprocal perspective as a super learner improves drug-target interaction prediction (MUSDTI).

Kevin Dick, Daniel G Kyrollos, Eric D Cosoreanu, Joseph Dooley, Joshua S Fryer, Shaun M Gordon, Nikhil Kharbanda, Martin Klamrowski, Patrick N L LaCasse, Thomas F Leung and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kevin DickDepartment of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada. kevin.dick@carleton.ca.
Daniel G KyrollosDepartment of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Eric D Cosoreanu *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Joseph Dooley *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Joshua S Fryer *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Shaun M Gordon *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Nikhil Kharbanda *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Martin Klamrowski *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Patrick N L LaCasse *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Thomas F Leung *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Muneeb A Nasir *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Chang Qiu *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Aisha S Robinson *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Derek Shao *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Boyan R Siromahov *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Evening Starlight *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Christophe Tran *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Christopher Wang *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
Yu-Kai Yang *Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.
James R GreenDepartment of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of novel drug-target interactions (DTI) is critical to drug discovery and drug repurposing to address contemporary medical and public health challenges presented by emergent diseases. Historically, computational methods have framed DTI prediction as a binary classification problem (indicating whether or not a drug physically interacts with a given protein target); however, framing the problem instead as a regression-based prediction of the physiochemical binding affinity is more meaningful. With growing databases of experimentally derived drug-target interactions (e.g. Davis, Binding-DB, and Kiba), deep learning-based DTI predictors can be effectively leveraged to achieve state-of-the-art (SOTA) performance. In this work, we formulated a DTI competition as part of the coursework for a senior undergraduate machine learning course and challenged students to generate component DTI models that might surpass SOTA models and effectively combine these component models as part of a meta-model using the Reciprocal Perspective (RP) multi-view learning framework. Following 6 weeks of concerted effort, 28 student-produced component deep-learning DTI models were leveraged in this work to produce a new SOTA RP-DTI model, denoted the Meta Undergraduate Student DTI (MUSDTI) model. Through a series of experiments we demonstrate that (1) RP can considerably improve SOTA DTI prediction, (2) our new double-cold experimental design is more appropriate for emergent DTI challenges, (3) that our novel MUSDTI meta-model outperforms SOTA models, (4) that RP can improve upon individual models as an ensembling method, and finally, (5) RP can be utilized for low computation transfer learning. This work introduces a number of important revelations for the field of DTI prediction and sequence-based, pairwise prediction in general.

Indexed as

Drug DevelopmentDrug DiscoveryComputer SimulationDrug InteractionsHumansMachine Learning

Identifiers

PMID35918366
PMCPMC9344797

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.